On 20 Oct 2026, BAO PHARMA-B (02659.HK) said NMPA approved the IND for BJ045 injection, a subcutaneous anti-CD20 antibody for use with IgG-degrading enzymes.
On 20 October 2026, CHK OIL (00632.HK) agreed to buy all of Zhejiang Dumei Electric for an intended RMB15 million, paying a RMB2.25 million deposit.
On 20 October 2026, BANK OF CHINA (03988.HK) completed a RMB50 billion write-down tier 2 capital bond issue at a 1.74% coupon with a 10-year term.
On 20 October 2026, ORBUSNEICH (06929.HK) said it completed the acquisition of Italian distributor MC Health S.r.l. on 15 October, a wholly-owned unit.
On 20 October 2026, TRANSCENTA-B (06628.HK) said it received RMB 95 million net of tax as the first payment for its CDMO asset sale, out of RMB 190 million.
On 20 October 2026, JIANGXI BANK (01916.HK) said the Jiangxi banking regulator cleared Qian Zheng as its chief compliance officer, effective 14 October 2026.
On 20 October 2026, HAIXI PHARMA (02637.HK) said its share award scheme trustee had bought 394,900 H shares, or 0.502% of issued shares, as at 16 October.
On 20 October 2026, TRIGIANT (01300.HK) said its Jiangsu Trigiant Technology unit was named a winning candidate in China Telecom's 2026-27 outdoor cable tender.
On 20 October 2026, ANKER (00668.HK) said it completed its registration change and obtained a new licence, with registered capital at RMB 588.05 million.
On 20 October 2026, SIHUAN PHARM (00460.HK) said its PCL filler and FL sodium hyaluronate solution, both developed by Meiyan Space, were approved in Hong Kong.
On October 20, 2026, the three major Hong Kong indices moved weaker in a choppy range, with the Hang Seng Index down 1.32%, the Hang Seng TECH Index down 1.52%, and the Hang Seng China Enterprises Index down 1.21%.
HIGHTIDE THERAPEUTICS (02511.HK) traded at HKD 3.100 on Oct 20 intraday, up 0.16%; its founder holds 16.21% via a family trust BVI per the prospectus.
JD INDUSTRIALS (07618.HK) listed on the Main Board of the Hong Kong Stock Exchange on December 11, 2025 at an offer price of HKD 14.10, bringing in seven cornerstone investors including M&G, CPE Investment and Anatole Investment Management for aggregate subscriptions of about USD 170 million; controlling shareholder Richard Liu controls about 76.90% of equity through The Max Smart Trust offshore family trust, and the company was added to the Stock Connect on March 9, 2026.
The lock-up on 4,464,000 H shares held by cornerstone investor WSH of JIANGXI BIO (06915.HK), 12.32% of the offer shares, expires on December 29, 2026.
Global X K-Pop And Culture Etf (03158.HK) fell 16.14% YTD but beat its index by 5-8 points; HYBE's Q3 revenue is expected to double on BTS tour demand.
IMPRO PRECISION (01286.HK) traded at HKD 6.115 intraday on Oct 20, up 0.16%, down 27.9% since entering Stock Connect on September 7; H1 revenue rose 23.2%.
